Figure 1. Sox2 expression is low or undetectable in triple negative breast cancer cell lines.
Western blot depicting Sox2, and Oct4A/B protein expression across ER− and ER+ breast cancer cell lines. Ntera2, a malignant human pluripotent embryonic carcinoma cell line, acts as a positive control for Sox2 and Oct4A/B.